ArticleBMC microbiology2025
Culture conditions impact the protein expression profile of Mycobacterium bovis BCG strains Moreau and Pasteur.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe Bacille Calmette-Guérin (BCG) vaccine, developed in the early 20th century, remains the only widely approved prophylactic against tuberculosis (TB). It was derived from an attenuated strain of Mycobacterium bovis. Its protective efficacy against pulmonary TB in adolescents and adults varies from 0 to 80%; genetic differences among worldwide vaccine strains contribute to this variation. The Brazilian vaccine strain used until 2017, BCG Moreau, is considered a primitive strain and more immunogenic, closer to the original BCG when compared to newer strains, such as BCG Pasteur. The characterization of BCG daughter-strains can contribute not only to a better understanding of the vaccine and its protective effect, but also to elucidating how different BCG culture conditions may contribute to the impact on the host's immune response. Thus, we aimed to characterize the differences in gene expression through the intracellular proteomic profile of BCG Moreau and Pasteur strains, cultivated in Sauton or 7H9 media, using two-dimensional electrophoresis (2DE) and mass spectrometry.
resultsComparative 2DE analysis of 7H9-cultured BCG strains showed 7 upregulated proteins in BCG Pasteur versus only 2 in BCG Moreau. This profile, however, was different for cultures obtained in the Sauton media, in which 6 proteins were upregulated in BCG Moreau compared to only 3 in BCG Pasteur. The comparison of 2DE profiles from the same strain under these 2 cultivation forms revealed that BCG Moreau regulates 19 proteins when grown in Sauton media, with 17 upregulated, while BCG Pasteur modulated the expression of 10 proteins, 7 upregulated when compared to growth in 7H9. These findings might indicate that the BCG Moreau strain needs to regulate its protein composition more strongly than Pasteur to adapt to adverse conditions of growth and cultivation.
conclusionsThe analysis of the intracellular 2DE profile reveals differences between cultivation methods as well as between the two M. bovis BCG vaccine strains, Moreau and Pasteur. Our results identify important proteins that may contribute to elucidating differences in vaccine efficacy, highlighting the importance of culture conditions when comparing different studies. These findings contribute to the characterization of the Brazilian vaccine strain, BCG Moreau under growth conditions similar to those used in vaccine production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.